Equities not available in your region
VRAX icon

Virax Biolabs Group (VRAX)

NASDAQ

2,65 $

−0,30 $ (

−10,02 %

)

1D
5D
1M
6M
1Y
5Y
Pre market

VRAX: 2,65 $ / ₿ 0 BTC / 4525 Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

2,95 $
2,50 $ - 28,50 $
$ 2,11M
6.67
1 071 562,00 $
796,94 dt
2,63 $ - 2,79 $
No

What is Virax Biolabs Group (VRAX)?

Virax Biolabs Group Ltd är ett innovativt bioteknikföretag fokuserat på att upptäcka immunsvar mot och diagnostisera virussjukdomar. Genom sin ViraxImmune-plattform och ImmuneSelect-portfölj av produkter och tjänster endast för forskningsbruk (RUO), bygger företaget ett erbjudande inom immunprofilering som omfattar RUO-analyser, prekliniska immunologitjänster och, på längre sikt, T-cellsbaserad diagnostik riktad mot postakuta infektionssyndrom (PAIS) som långvarig COVID och andra kroniska tillstånd kopplade till immun dysreglering.

The Virax Biolabs Group (VRAX) stock price has been falling

The Virax Biolabs Group Limited Ordinary Shares (VRAX) stock pre-market price today is 2,65 $, reflecting a −10,02 % pre-market move since the market last closed. The company’s market capitalization stands at $ 2,11M, with a daily trading volume of $ 1,07M shares. The previous closing price was 2,95 $.

Get started with Virax Biolabs Group (VRAX)

Ready to get started? Follow the steps below, or read our guide on how to buy Virax Biolabs Group stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy VRAX

Search for VRAX in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy VRAX.

VRAX FAQs

VRAX is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

VRAX is in the Biotechnology industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, Virax Biolabs Group Limited Ordinary Shares (VRAX) has traded between a low of 2,50 $ and a high of 28,50 $.

VRAX is in the Biotechnology industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in Virax Biolabs Group? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
VRAX icon
VRAX

Only available to USA clients through the Kraken app
or Kraken Pro.

Explore other stocks

Most active

Explore the most-traded stocks today

Top gainers

Browse today’s biggest stock market winners

Top losers

Compare the worst-performing stocks of 
the day

YOTAR icon

YOTAR

JDZG icon

JDZG

INLF icon

INLF

MDCXW icon

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.